High Circulating Sphingosine 1-Phosphate is a Risk Factor for Osteoporotic Fracture Independent of Fracture Risk Assessm
- PDF / 945,876 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 6 Downloads / 156 Views
ORIGINAL RESEARCH
High Circulating Sphingosine 1‑Phosphate is a Risk Factor for Osteoporotic Fracture Independent of Fracture Risk Assessment Tool Seung Hun Lee1 · Jee Yang Lee1 · Kyeong‑Hye Lim1 · Young‑Sun Lee2 · Seong‑Hee Kim3 · Sooyoung Choi3 · Seong‑Hwan Cho3 · Jung‑Min Koh1 Received: 21 April 2020 / Accepted: 14 July 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Circulating sphingosine 1-phosphate (S1P) levels may be a biomarker for osteoporotic fracture (OF). This study assessed whether the addition of S1P levels to the fracture risk assessment tool (FRAX) could improve predictability of OF risk. Plasma S1P concentrations and FRAX variables were measured in 81 subjects with and 341 subjects without OF. S1P levels were higher in subjects with than those without OF (3.11 ± 0.13 μmol/L vs. 2.65 ± 0.61 μmol/L, P = 0.001). Higher S1P levels were associated with a higher likelihood of OF (odds ratio [OR] = 1.33, 95% confidence interval [CI] = 1.05–1.68), even after adjusting for FRAX probabilities. Compared with the lowest S1P tertile, subjects in the middle (OR = 3.37, 95% CI = 1.58–7.22) and highest (OR = 3.65, 95% CI = 1.66–8.03) S1P tertiles had higher rates of OF after adjustment. The addition of S1P levels to FRAX probabilities improved the area under the receiver-operating characteristics curve (AUC) for OF, from 0.708 to 0.769 (P = 0.013), as well as enhancing category-free net reclassification improvement (NRI = 0.504, 95% CI = 0.271–0.737, P
Data Loading...
